Updated Financial Calendar for 2022
April 28, 2022 10:13 ET
|
ORPHAZYME A/S
Orphazyme A/S in restructuringCompany announcement No. 22/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, April 28, 2022 – Orphazyme A/S in restructuring (ORPHA.CO;...
Statutory restructuring plan adopted by creditors
April 07, 2022 06:08 ET
|
ORPHAZYME A/S
Orphazyme A/S in restructuringCompany announcementNo. 20/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, April 7, 2022 – Orphazyme A/S in restructuring...
Updated Financial Calendar for 2022
April 06, 2022 08:48 ET
|
ORPHAZYME A/S
Orphazyme A/S in restructuringCompany announcement No. 19/2022 www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, April 6, 2022 – Orphazyme A/S in restructuring...
Notice received from the Depositary to holders of ADSs regarding termination of Deposit Agreement
April 06, 2022 04:00 ET
|
ORPHAZYME A/S
Orphazyme A/S in restructuringCompany announcementNo. 18/2022www.orphazyme.comCompany Registration No. 32266355 NOTICE TO HOLDERS OF AMERICAN DEPOSITARY SHARES (“ADSs”) EVIDENCED BYAMERICAN...
Correction: Proposal for a statutory restructuring plan
April 04, 2022 13:44 ET
|
ORPHAZYME A/S
Orphazyme A/S in restructuringCompany announcementNo. 17/2022Inside information www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, April 4, 2022 – Orphazyme A/S in...
Voluntary delisting of ADSs has become effective
March 31, 2022 17:37 ET
|
ORPHAZYME A/S
Orphazyme A/S in restructuringCompany announcementNo. 16/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 31, 2022 – Orphazyme A/S in restructuring (ORPHA.CO)...
Proposal for a statutory restructuring plan
March 31, 2022 12:00 ET
|
ORPHAZYME A/S
Orphazyme A/S in restructuringCompany announcementNo. 15/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 31, 2022 – Orphazyme A/S in...
Updated Financial Calendar for 2022
March 29, 2022 07:15 ET
|
ORPHAZYME A/S
Orphazyme A/S in restructuringCompany announcementNo. 14/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 29, 2022 – Orphazyme A/S in restructuring (ORPHA.CO; ORPH)...
Orphazyme announces withdrawal of European Marketing Authorisation Application for arimoclomol for the treatment of Niemann-Pick disease type C
March 22, 2022 06:54 ET
|
ORPHAZYME A/S
Orphazyme A/SCompany announcementNo. 13/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Decision to withdraw the European Marketing Authorisation Application comes ahead of...
Orphazyme A/S has filed for voluntary delisting of ADSs
March 21, 2022 17:44 ET
|
ORPHAZYME A/S
Orphazyme A/SCompany announcementNo. 12/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 21, 2022 – Orphazyme A/S (ORPHA.CO; ORPH) (“Orphazyme” or the “Company”), a...